JBS financials
$11.29−0.70%
Close Sep 30, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 |
|---|---|
| Revenue | $86.18B |
| Gross profit | $11.30B |
| Gross margin | 13.1% |
| Operating income | $4.16B |
| Net income | $2.02B |
| Net margin | 2.3% |
| Diluted EPS | $1.89 |
| EBITDA | $6.47B |
| Operating cash flow | $2.93B |
| Free cash flow | $825.6M |
| Diluted shares | 1,068.5M |
Balance sheet
| Period end | Dec 31 |
|---|---|
| Cash & equivalents | $4.72B |
| Short-term investments | $0.00 |
| Total debt | $21.09B |
| Total assets | $45.16B |
| Total liabilities | $35.63B |
| Shareholders' equity | $9.52B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology